Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Hirotsu

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
Nucleic Acids Research|September 12, 2012
Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networksYosuke Hirotsu, Fumiki Katsuoka, Ryo Funayama, et al.
JTO Clinical and Research Reports|May 2, 2022
<i>TP53</i> Loss of Heterozygosity Induces De Novo SCLC Formation in EGFR-Mutated Lung Adenocarcinoma: A Case ReportKei Kunimasa, Yosuke Hirotsu, Kenji Amemiya, et al.
Cancer Science|August 2, 2019
Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancerYosuke Hirotsu, Hitoshi Yokoyama, Kenji Amemiya, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 3, 2021
Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19Yosuke Hirotsu, Hiroki Sugiura, Makoto Maejima, et al.
The Annals of Thoracic Surgery|December 13, 2021
Lung Cancer Surgery With Persistent COVID-19 InfectionTakahiro Nakagomi, Taichiro Goto, Yosuke Hirotsu, et al.
Breast Cancer (Tokyo, Japan)|May 31, 2015
Willingness of Japanese patients with breast cancer to have genetic testing of BRCA without burden of expensesHiroshi Nakagomi, Ikuko Sakamoto, Yosuke Hirotsu, et al.
Cancer Science|December 8, 2017
Combined annotation-dependent depletion score for BRCA1/2 variants in patients with breast and/or ovarian cancerHiroshi Nakagomi, Hitoshi Mochizuki, Masayuki Inoue, et al.
Cancer|October 7, 2015
BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancerIkuko Sakamoto, Yosuke Hirotsu, Hiroshi Nakagomi, et al.
Scientific Reports|February 27, 2020
Dual-molecular barcode sequencing detects rare variants in tumor and cell free DNA in plasmaYosuke Hirotsu, Sotaro Otake, Hiroshi Ohyama, et al.
Cancer Medicine|May 21, 2022
Simple IHC reveals complex MMR alternations than PCR assays: Validation by LCM and next-generation sequencingKenji Amemiya, Yosuke Hirotsu, Yuki Nagakubo, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Nucleic Acids Research|September 12, 2012
Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networksYosuke Hirotsu, Fumiki Katsuoka, Ryo Funayama, et al.
JTO Clinical and Research Reports|May 2, 2022
<i>TP53</i> Loss of Heterozygosity Induces De Novo SCLC Formation in EGFR-Mutated Lung Adenocarcinoma: A Case ReportKei Kunimasa, Yosuke Hirotsu, Kenji Amemiya, et al.
Cancer Science|August 2, 2019
Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancerYosuke Hirotsu, Hitoshi Yokoyama, Kenji Amemiya, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 3, 2021
Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19Yosuke Hirotsu, Hiroki Sugiura, Makoto Maejima, et al.
The Annals of Thoracic Surgery|December 13, 2021
Lung Cancer Surgery With Persistent COVID-19 InfectionTakahiro Nakagomi, Taichiro Goto, Yosuke Hirotsu, et al.
Breast Cancer (Tokyo, Japan)|May 31, 2015
Willingness of Japanese patients with breast cancer to have genetic testing of BRCA without burden of expensesHiroshi Nakagomi, Ikuko Sakamoto, Yosuke Hirotsu, et al.
Cancer Science|December 8, 2017
Combined annotation-dependent depletion score for BRCA1/2 variants in patients with breast and/or ovarian cancerHiroshi Nakagomi, Hitoshi Mochizuki, Masayuki Inoue, et al.
Cancer|October 7, 2015
BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancerIkuko Sakamoto, Yosuke Hirotsu, Hiroshi Nakagomi, et al.
Scientific Reports|February 27, 2020
Dual-molecular barcode sequencing detects rare variants in tumor and cell free DNA in plasmaYosuke Hirotsu, Sotaro Otake, Hiroshi Ohyama, et al.
Cancer Medicine|May 21, 2022
Simple IHC reveals complex MMR alternations than PCR assays: Validation by LCM and next-generation sequencingKenji Amemiya, Yosuke Hirotsu, Yuki Nagakubo, et al.
Pageof 13